HIV proteins disrupt a network of phosphatidylinositol (4,5)‐bisphosphate binding sites on the dopamine transporter to regulate amphetamine behaviours

Amphetamine (AMPH) use has been linked to human immunodeficiency virus (HIV) transmission because HIV can spread through unprotected sex that is associated with AMPH use disorder (AUD). Thus, AUD and HIV have been termed a double epidemic. In this bidirectional relationship, the role played by AUD in HIV‐dependent neuropathogenesis is well documented. By contrast, how HIV infection regulates the development of AUD remains elusive. In rodents, expression of HIV viral proteins, such as the trans‐activator of transcription (Tat), enhances AMPH escalation (i.e. a progressive intensification of drug use), a Diagnostic and Statistical Manual of Mental Disorders (DSM‐5) criteria for addiction. In humans, HIV infection increases AMPH frequency of use, as well as the total amount used. Thus, it is possible that HIV/HIV proteins promote the progression of AUD. AMPH‐associated behaviours stem, at least in part, from the ability of AMPH to reverse the dopamine (DA) transporter (DAT) function, causing non‐vesicular DA release (NVDR) and an increase in extracellular DA. Previously, we provided the first evidence that specific domains of DAT engage in direct association with the plasma membrane lipid, phosphatidylinositol 4,5‐bisphosphate (PIP 2 ). These interactions are essential for AMPH‐induced NVDR and specific behaviours. HIV Tat is a protein that binds PIP 2 through its basic domain. We demonstrate that Tat impairs NVDR by disrupting the network of PIP 2 binding sites on DAT. Our study provides an atomic scale mechanistic description on how Tat disrupts human DAT/PIP 2 association and blunts AMPH‐induced NVDR. Using Drosophila as an animal model, we show that Tat by blunting NVDR in the setting of AUD promotes AMPH escalation. image Key points Human immunodeficiency virus (HIV) trans‐activator of transcription (Tat) impairs non‐vesicular dopamine (DA) release (NVDR) by disrupting the network of PIP 2 binding sites on human Da transporter (DAT). Our study provides an atomic scale mechanistic description on how Tat disrupts human DAT/phosphatidylinositol 4,5‐bisphosphate association and blunts amphetamine (AMPH)‐induced NVDR. We associate Tat blunting of NVDR to the ability of Tat to foster AMPH escalation, using Drosophila as an animal model.

Authors

Institutions

Publication Details

Journal
The Journal of Physiology
Published
2026-11-18
DOI
https://doi.org/10.1113/jp291975
Primary Topic
Neurotransmitter Receptor Influence on Behavior
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HIV proteins disrupt a network of phosphatidylinositol (4,5)‐bisphosphate binding sites on the dopamine transporter to regulate amphetamine behaviours

Yanqi Zhu, Mary Hongying Cheng, Clarence Haddon Mullins, Aurelio Galli et al.
The Journal of Physiology
Neurotransmitter Receptor Influence on Behavior
article

HIV proteins disrupt a network of phosphatidylinositol (4,5)‐bisphosphate binding sites on the dopamine transporter to regulate amphetamine behaviours

Yanqi Zhu, Mary Hongying Cheng, Clarence Haddon Mullins, Aurelio Galli, Heinrich J. G. Matthies, Angela M. Carter, Daniele Zanella, İvet Bahar, Diksha Parwana, Branden Duyvestyn, Cesar E. Hernandez, Hunter S Goffinet, Siddhartha Nakkella
article en

Abstract

Amphetamine (AMPH) use has been linked to human immunodeficiency virus (HIV) transmission because HIV can spread through unprotected sex that is associated with AMPH use disorder (AUD). Thus, AUD and HIV have been termed a double epidemic. In this bidirectional relationship, the role played by AUD in HIV‐dependent neuropathogenesis is well documented. By contrast, how HIV infection regulates the development of AUD remains elusive. In rodents, expression of HIV viral proteins, such as the trans‐activator of transcription (Tat), enhances AMPH escalation (i.e. a progressive intensification of drug use), a Diagnostic and Statistical Manual of Mental Disorders (DSM‐5) criteria for addiction. In humans, HIV infection increases AMPH frequency of use, as well as the total amount used. Thus, it is possible that HIV/HIV proteins promote the progression of AUD. AMPH‐associated behaviours stem, at least in part, from the ability of AMPH to reverse the dopamine (DA) transporter (DAT) function, causing non‐vesicular DA release (NVDR) and an increase in extracellular DA. Previously, we provided the first evidence that specific domains of DAT engage in direct association with the plasma membrane lipid, phosphatidylinositol 4,5‐bisphosphate (PIP 2 ). These interactions are essential for AMPH‐induced NVDR and specific behaviours. HIV Tat is a protein that binds PIP 2 through its basic domain. We demonstrate that Tat impairs NVDR by disrupting the network of PIP 2 binding sites on DAT. Our study provides an atomic scale mechanistic description on how Tat disrupts human DAT/PIP 2 association and blunts AMPH‐induced NVDR. Using Drosophila as an animal model, we show that Tat by blunting NVDR in the setting of AUD promotes AMPH escalation. image Key points Human immunodeficiency virus (HIV) trans‐activator of transcription (Tat) impairs non‐vesicular dopamine (DA) release (NVDR) by disrupting the network of PIP 2 binding sites on human Da transporter (DAT). Our study provides an atomic scale mechanistic description on how Tat disrupts human DAT/phosphatidylinositol 4,5‐bisphosphate association and blunts amphetamine (AMPH)‐induced NVDR. We associate Tat blunting of NVDR to the ability of Tat to foster AMPH escalation, using Drosophila as an animal model.

The Journal of Physiology
University of Alabama at Birmingham (US), UAB Medicine (US), Stony Brook University (US)
Neurotransmitter Receptor Influence on Behavior
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon